The Australian radiopharmaceutical company's TLX101-Px diagnostic agent received marketing authorization application ...

Higher vitamin D levels in early midlife are associated with lower tau deposition in later midlife among adults without dementia.

Mass General Brigham researchers used long-term data and a blood test for the biomarker pTau217 to identify the earliest signs of Alzheimer’s disease in cognitively healthy adults.

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the marketing authorization application (MAA) filed in Europe for TLX101-Px (O-(2-[18 F]fluoroethyl)-L-tyrosine, 18 ...

A blood test can now detect Alzheimer’s disease early, and a Canton neurologist is among the first in the country using it.

The idea is straightforward: Take a blood test now, even without symptoms, and learn if you could some day develop ...

Swiss biotech AC Immune has revealed Phase I results showing the first-ever in vivo images of TDP-43 protein in the human brain using its PET tracer ACI-19626. Presented at a leading Alzheimer’s and ...

OpenAI Foundation pledges $100 million to Alzheimer’s research, highlighting AI’s potential to accelerate diagnosis, drug ...

Should you receive a diagnosis of AD, many factors shape how symptoms unfold. The brain, even when under siege, retains an ...

The free tests aim to help identify Alzheimers symptoms in their early stages, when treatment is most likely to be effective.

Alzheimer’s disease may begin its biological progression far earlier than symptoms suggest, with subtle shifts in brain and blood markers emerging decades in advance.

I plodded toward my car, lugging a heavy laptop, a lunch bag, the breast pump and a handbag, and looking like a pack mule on ...